Ahmed Eltelbany, MD, MPH

Cleveland Clinic
Cleveland, OH

Presentation(s):

• 68 - Use of GLP1 Agonists or SGLT2 Inhibitors in Non-Alcoholic Steatohepatitis Patients With T2DM Is Associated With a Lower Risk of Cirrhosis: A Nationwide Population-Based Study

  Wednesday, October 26, 2022
  9:15 AM – 9:30 AM ET